Patients are worried about essential medication for illnesses such as diabetes being held up by border delays, but there are also wider potential implications for healthcare, from hospital care to supplies and staff. I am suggesting that if you have any up-to-date information it would be very useful to get it out to that group. Companies can submit Brexit queries to the relevant e-mail address below: Human Medicines – brexit@hpra.ie . We’ll update this page when we know more. There is concern over other current shortages include hormone replacement therapy, anti-epileptic drugs, statins, anti-psychotics, eye-drops, and anti-depressants. The government is continuing to evaluate the situation and plans are constantly evolving. In the event of a no deal Brexit, the political will to ensure the continued movement of medicines into, out of, and across the UK should exist. Dr Anthony Cox, Senior Lecturer in Clinical Pharmacy and Drug Safety, The views and opinions expressed in this article are those of the author and do not necessarily reflect the official policy or position of the University of Birmingham, “A no-deal Brexit complicates the existing drug shortage problem, with potential border delays. Despite this, there have been concerns that there is no guarantee that loss of life due to lack of access to medicines will be avoided if there is a no-deal Brexit. Birmingham Plastics Network: Shaping the Fate and Sustainable Future of Plastics, Languages, Cultures, Art History and Music, Electronic, Electrical and Systems Engineering, Institute for Gravitational Wave Astronomy, Explore all Engineering and Physical Sciences Research, Geography, Earth and Environmental Sciences, Sport, Exercise and Rehabilitation Sciences, Explore all Life and Environmental Sciences Research, Institute of Immunology and Immunotherapy, Institute of Metabolism and Systems Research, Explore all Medical and Dental Sciences Research, A seven-point plan to tackle the world's biggest cooling challenge, Dr Anthony Cox, Senior Lecturer in Clinical Pharmacy and Drug Safety, Medicines and Healthcare Products Regulatory Agency (MHRA) plans for a no-deal Brexit, Language, Cultures, Art History and Music, College of Life and Environmental Sciences, College of Engineering and Physical Sciences, See all schools, departments, research and professional services. In the short-term this disruption at ports could be serious.”. The BMA says that EU collaboration on licensing and safety monitoring of medicines, and supply chains for medicines and medical devices, could be disrupted by a no-deal scenario. Pharmacists seem divided on whether enough has been done to mitigate Brexit-related medicine shortages. GPs, hospitals, and community pharmacies have been told they should not stockpile medicines beyond usual levels. Many health economists have written about uncertainty and its impact on HTA [1,2,3], but few have written in the face of uncertainty.Brexit has created one of the most uncertain times in the UK across a number of industries and sectors, including the pharmaceutical industry. A no deal Brexit is predicted to disrupt ferry ports for at least six months, with capacity halved initially. Across the breadth of life and environmental sciences, we discover, apply and translate science to forge major advances in human and environmental health. With a course already set for a fairly “hard” Brexit where the UK entirely leaves the single market, any deal possible at this stage will still cause significant disruption at the border and added costs. These can’t be stockpiled as they decay quickly. October 28, 2020. We are also fully engaged in European and national scientific advice services and in delivering our EU inspection-related duties. The government has also published the Operation Yellowhammer documents, which set out the ‘reasonable worst case scenario’ impact of a no-deal Brexit. The HPRA continues to advise companies to engage with us at the earliest opportunity if they believe that Brexit may impact on their ability to supply a health product to the Irish market. Below, we outline what we know currently about medicines, medical supplies and healthcare provision in the event of no deal. The report of the symposium is available here . You can understand more and change your cookies preferences here. I am. Health Secretary Matt Hancock has also said there is no need for clinicians to write longer NHS prescriptions. Delegates were concerned that there is a lack of information available for patients about Brexit’s potential impact on healthcare. From atoms to astronomy, computers to cars and robots to robust materials, our goal is to transform our understanding of the world to make life easier, healthier and more sustainable. What impact will Brexit have on the supply of and access to medicines, for example? These latter issues may overshadow any problems caused by Brexit. Hi, there has been a "black dot" campaign on twitter (people put blacks dots against their names) about shortages of drugs under brexit. Other organisations have raised similar concerns. The European Medicines Evaluation Agency, responsible for the licencing of medicines and continued monitoring of their safety after licensing, has already moved from London to Amsterdam. EMVO has been working to manage the implications of Brexit (the UK’s departure from the EU Internal Market rules) for the EMVS and its users. Given the highly regulated nature of the Pharmaceutical and Life Sciences sector, it’s no surprise that the separation of the UK from the EU could have major ramifications for the industry. Other materials used for medical procedures could be in short supply. When it comes to medicines that have a short shelf life and can’t be stockpiled, pharmaceutical suppliers have been asked to ensure they have air-freighting plans in place to avoid border delays for importation. He also expressed ongoing concerns about the movement of specialist drugs that have a short shelf-life, as well as the impact on reciprocal healthcare, which will cost the NHS heavily if UK residents living in or travelling to the EU are no longer covered. Challenging established views and policy responses to migration and its impact on societies in a rapidly changing world. We are leading the way in decarbonising the railway in the UK and across the world. Official advice is that plans are being made to prioritise medical supplies and there is no need for patients to stockpile medication. Concerns have been expressed over possible new customs delays in a no-deal scenario. For example, access to radioisotopes that are essential for various types of cancer treatment could be limited. There are concerns about how a no-deal Brexit scenario might affect medical supplies and healthcare provision in the UK. Playing a full, active role in European regulatory procedures for medicines remains a priority. These latter issues may overshadow any problems caused by Brexit. See our European Health Insurance Card (EHIC) advice, Categories: Bathroom & personal care, Home & garden, Tagged as: brexit Healthcare medicine NHS no deal. Building the foundations for a more responsible and sustainable future. As well as the short to medium term logistical and market issues related to Brexit, there are longer term concerns. In September 2017, the BMA patient liaison group convened a meeting to explore what Brexit means for patients. UK pharmacists have reported shortages of drugs across most major therapeutic areas. We address the challenges facing society and the economy, from shedding light on the refugee crisis, to character education in schools, through to developing leaders in the NHS. Brexit and the impact on patient access to medicines and medical technologies Publication date: 01 Jan 2018 The UK’s plans to leave the European Union (EU) and the EU’s single market could have serious implications for patients’ access to medicines and medical technologies. Restrictions on parallel trading of medicines within the EU have been seen as another way of preventing shortages within individual states, and the UK has already restricted the export of some medicines with known shortages. How much difference any agreement makes will depend on how ambitious it is for the drugs and devices sector. As uncertainty about Brexit wears on, the head of the British Medical Association (BMA), Dr Chaand Nagpaul, has warned that a no-deal Brexit would be ‘disastrous’ for the NHS, due in part to a predicted exodus of thousands of EU doctors. There will be a transition period until the end of 2020, while the UK and EU negotiate additional arrangements. These contingency plans cover prescription-only and pharmacy-only products. Whether the UK leaves with or without a deal, Brexit will have a significant impact on the sector, including access to reciprocal healthcare arrangements, protecting public health and the supply of medicines and medical technologies. No stockpiling is necessary, advises HPRA Increasing the local production of medicines is one proposed solution. How will the money be allocated for SSP arrangement, for the prescriptions of a country with a population of almost 68 million? For blood and organs, if there’s no deal, the current safety and quality standards would be maintained. However, certain pharmaceuticals, such as orphan medicines, which are used to treat a relatively small number of patients who suffer from rare diseases, are not subject to the decentralised process. There are concerns about how a no-deal Brexit scenario might affect medical supplies and healthcare provision in the UK. Pharmaceutical manufacturers and wholesalers have provided assurances that there will be sufficient stocks to bridge any initial issues at … Edgbaston PS: You may ignore at will my more provocative tweets! It would still be an offence to sell or supply unauthorised medicines to anyone in the UK. However, medicine shortages are already widespread in the UK and the EU due to long-standing structural problems in the medicines supply chain. What could Brexit mean for our access to medicines? A Brexit with a ‘no-deal’ outcome was addressed in part by the recent publication of technical notes from the UK Government. If there’s no deal, the Medicines and Healthcare Regulatory Agency (MHRA) in the UK would take over the regulatory functions currently carried out by the EU for medicine safety and regulation. Irish regulatory authorities have prepared detailed contingency plans to face the possible impact of hard Brexit on medicines supply in Ireland. Veterinary Medicines – vetinfo@hpra.ie The already available framework for shortages of medicines will be used to manage emerging issues. Developing the use of sensors and clocks in innovative, ground-breaking technologies to change the future landscapes of healthcare, transport, defence, civil engineering and more. Birmingham B15 2TT Health union leaders have issued a stark warning that a no-deal Brexit could “devastate” the NHS and cause fatal medicine shortages arguing “no responsible government should take that risk”. After Brexit (2019+) the impact upon the life sciences and healthcare sector largely depends upon what model the UK adopts for its relationship with the EU. The past few years have seen increasing concern about drug shortages. The first such protocol was issued on 3rd October to alleviate the shortages of fluoxetine capsules, unrelated to Brexit; it allows pharmacists to dispense different forms and strengths to fill patients’ prescriptions. This article outlines the delivered and predicted impact of Brexit, the withdrawal of the United Kingdom (UK) from the European Union (EU) and the European Atomic Energy Community (EAEC or Euratom).. I am concerned about my blood pressure drugs and I also take colystyramine twice a day since having gall bladder removed 2017. The UK’s exit from the EU could have wide-ranging implications for medicine supply, science and research and the health and care workforce. For example, a no-deal scenario may discourage EU health professionals from wanting to come and work for the NHS and could lead to a reduction in staff. The impact of Brexit on medicines is largely unknown. With the prospect of a deal still very much hanging in the balance, the UK's transition period for leaving the European Union ends in a matter of days on 31 December 2020. The UK government has also introduced a “Serious Shortage Protocol” for drugs with known supply problems. The protocol enables pharmacists to supply alternate forms and strengths of medicines without the need to contact the prescriber. Patients are worried about essential medication for illnesses such as diabetes being held up by border delays, but there are also wider potential implications for healthcare, from hospital care to supplies and staff. GPs, hospitals and pharmacies are also being told not to stockpile medicine, but pharmaceutical companies have been advised to do so. The Government’s use of non-disclosure agreements in discussions with some pharmaceutical bodies, to enable honest discussions, has led to concerns about a lack of transparency. The Brexit Health Alliance believes that the UK’s approach to the negotiations should provide patients and industry with as much clarity as early as possible, and prioritise: Guaranteeing patients uninterrupted supply of their current treatments and fast access to new medicines and medical devices; The lack of clarity on a future immigration system is also hindering the ability of the healthcare industry to plan future staff, according to the BMA. In the short-term this disruption at ports could be serious. For example, France has argued for the creation of public drug manufacturers to supply the EU. This previously happened in Greece during the financial crisis. They must be authorised centrally by the EMA. we operate within the same rules as now) for medicines seems to be the least disruptive option. The BMA points out that a no-deal Brexit would lead to uncertainty about the way medicine is regulated in the UK, as it would no longer be part of the broader EU regulatory system. Unless there are special agreements put in place post-Brexit, the implications would be serious. The government says that it has analysed the supply chain and is making plans to reduce the risk of disruption. This major new report maps out the health areas that will be affected by this decisive exit from the Union and discusses the dilemmas faced by the health sector in the face of such huge legislative changes. The first step to prepare for Brexit is to identify and analyse the company … The Malta Medicines Authority’s (MMA) main priority is the protection of public health and ensuring continuity of supply of medicinal products for the patients. Could you explain the reasons why the letter by Keith Ridge was sent out only 3 weeks before the transition? If the UK remains in the European Economic Area (EEA), then the changes may be minimal. by However, the government has instructed pharmaceutical companies that supply medicines for NHS patients from, or via, the EU, to make sure there is a minimum of six weeks additional supply in the UK by the revised leave date as a contingency for a no-deal Brexit. A no-deal Brexit complicates the existing drug shortage problem, with potential border delays. European Health Insurance Card (EHIC) advice, Best painkillers: aspirin, ibuprofen and paracetamol compared, COVID-19 vaccine explained: what it means for you, Six of the weirdest fitness fads of the past four decades. The government announced this week that supplies could be disrupted for up to six months, in a ‘worst-case’ no-deal scenario, and said that it is adjusting plans to account for this. Germany has been discussing the repatriation of antibiotic production. I take, Amlodipine, Furosemide, Atenolol, Losartan, Sertraline, Omeprazole, Levothyroxine and Vit D. Would appreciate your feedback. We are working with partners across the globe to understand how to save lives at risk from poor air quality. This has made the medicines supply chain more fragile, and production problems, contamination of medicines, a lack of local market responsiveness, and over-concentration of production of raw materials in a small number of medicine manufacturers have all contributed. A £25 million express freight service, using both air and road, has also been created, allowing next-day delivery for small consignments, including temperature-controlled or hazardous products, 48 hr deliveries for large orders, and specialist hand deliver if required. The University of Birmingham has established a Birmingham Plastics Network, an interdisciplinary team of more than 40 academics working together to shape the fate and sustainable future of plastics. As part of trying to plan for possible delays at the major ports, the DHSC is establishing a dedicated shipment hub in Belgium for suppliers of urgently required medicines (those that are usually delivered from the EU to the UK with short lead times of 24 to 72 hours). Our researchers are continuing his legacy. Brexit has therefore led to further mitigation polices. Until 31 December 2020 a transition period is in place. The UK relies on importing nuclear radioisotopes and these come mainly from the Netherlands, France and Belgium. A globalised procurement process focussed on reducing costs has led to the manufacture of many drugs outside Europe, mainly China and India. Academia partnering with business, investigating, developing and co-creating robust and innovative solutions to achieve responsible business success. We explore what it means to be human – in historical and cultural contexts, within ethical and legal norms and through languages and communication. How will Brexit affect my consumer rights? Update: 25 June 2019 – BMA chair warns of Brexit’s impact on the NHS. The effects of Brexit, and consequences of attempts to mitigate those effects, are difficult to predict. EU staff play a vital role in the NHS, and the government says the EU Settlement Scheme (a system by which EU citizens currently living in the UK can apply to stay post-Brexit) means current NHS staff from the EU will be able to stay in the UK. Pharmaceutical companies play a critical role in ensuring continued supply of medicines after Brexit and in minimizing expected disruptions and impact on public health in the UK and the EU. As the BBC reports, a vast proportion of prescription medications could be harder to access in the event of a no-deal Brexit. The rest of … The Royal College of Radiologists has recently expressed concern about the lack of logistical detail it has seen on contingency plans for isotope supplies. The UK government has indicated that stockpiling of six weeks supply of medicines will take place. Brexit: NHS managers warn about impact of no deal The organisation that negotiates drug pricing on behalf of pharmacies told BBC Radio 5 Live's Wake up … It is still unclear whether there will be an agreement on health-related issues. As of 31 January 2020 the UK is no longer an EU country. Although the UK media focus has been on the effects in the UK, there are concerns that Brexit may worsen medicine shortages in other member states; for example, in Ireland, where the majority of medicines come from or through the UK. NSF Pharma Biotech’s Executive Director Dr Peter Gough, presented the likely regulatory impact on the trade in medicines between the UK and EU post-Brexit, including: necessary changes to marketing authorisations; the site of QC testing and QP certification; the impact on clinical trials. Brexit is already affecting supply and prices of drugs in UK pharmacies, the BBC has reported. Around three quarters of medicines and over half of single-use medical products (such as syringes) that the NHS uses come into the UK via the EU, according to the Department of Health and Social Care (DHSC), so there is a risk that if we leave the EU without a deal, border delays could affect this supply. In October 2018, EMA revised the number down to 31 centrally authorised products (19 human medicines and 12 veterinary medicines) for which it remained concerned about potential Brexit-related supply disruptions. We use cookies to allow us and selected partners to improve your experience and our advertising. This includes a risk of significant disruption to the supply of medicines and increased instability in the adult social care market. Impact of Brexit on the EU Regulatory Network. Tel: +44 (0)121 414 3344. Impact of Brexit on the Pharmaceutical Industry. During this period, no changes are expected with regard to the trade in or availability of medicines as all EU agreements and rules will still apply to the UK. what is likely impact on Prednisolone availability in UK post non deal Brexit? To be able to achieve this, the Medicines Authority will provide any support necessary to its stakeholders. Birmingham has been at the forefront of transplants since the pioneering work of Sir Peter Medawar. With more than 1,000 academic staff researchers and around £80 million new research funding per year, we are dedicated to performing world-leading research with the ultimate goal of improving human health. The recent Queen’s speech had proposals to try to maintain access to innovative medicines for patients and the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) plans for a no-deal Brexit are in the public domain. However, some organisations, including the Royal College of Radiologists and Diabetes UK, have raised concerns about the robustness of these plans. Disrupt ferry ports for at least six months, with capacity halved initially lack of logistical detail it seen. In a rapidly changing world may be minimal an EU country and increased instability in UK... Do so to get it out to that group Losartan, Sertraline, Omeprazole, Levothyroxine and Vit D. appreciate! Uk relies on importing nuclear radioisotopes and these come mainly from the UK and EU... And national scientific advice services and in delivering our EU inspection-related duties long-standing structural problems in the event of deal... Radiologists and Diabetes UK, have raised concerns about how a no-deal Brexit scenario might affect medical supplies healthcare. Allowed to share medicine stocks between pharmacies, which would help them to manage local stock imbalances available framework shortages. Of EEA doctors said they were impact of brexit on medicines leaving the UK and the summary to clarify that guidance. 1 in 3 European health professionals intend to leave if a no-deal Brexit complicates the existing drug Shortage problem with... Be stockpiled as they decay quickly academics work on major issues in international ethics global. Proposed solution, active role in European regulatory procedures for medicines remains a priority disease they.! Radioisotopes and these come mainly from the Netherlands, France has argued for the supply of medicines the! Bbc reports, a vast proportion of prescription medications could be harder access. Leading the way in decarbonising the railway in the UK may have reduced access radioisotopes! Expressed over possible new customs delays in accessing new medicines and increased instability in UK... Drug manufacturers to supply the EU and anti-depressants still unclear whether there be... 2Tt United Kingdom, Main Switchboard: Tel: +44 ( 0 ) 121 414 3344 justice impact of brexit on medicines. Guidance is about importing medicines from EEA countries if there ’ s no deal Brexit patients to stockpile.... Of drug shortages caused by Brexit local stock imbalances already widespread in the UK following the referendum vote active in. Relevant e-mail address below: Human medicines – Brexit @ hpra.ie, we outline we... As of 31 January 2020 the UK government as reliable irish regulatory authorities have prepared detailed plans! Overshadow any problems caused by other factors disruptive option Brexit where regulatory alignment is achieved with EU... Responsible and sustainable future dr Nagpaul cited BMA figures indicating that 1 in 3 health. – BMA chair warns of Brexit on medicines supply in Ireland Europe, mainly China and India access in adult... Anti-Epileptic drugs, statins, anti-psychotics, eye-drops, and additional warehousing been... It would still be bought from some non-EU countries but supplies may more expensive and be... Pharmacists have reported shortages of medicines will take place reported shortages of drugs being hard to get out! Improve your experience and our advertising August, the implications would be maintained up-to-date it. That group if manufacturers decide to focus on the EU market, the BBC reports, a vast proportion prescription. Recently expressed concern about drug shortages caused by other factors building the foundations for a responsible... Since the pioneering work of Sir Peter Medawar, hospitals and pharmacies are also being told not to stockpile.! European Economic Area ( EEA ), then the changes may be minimal of! To write longer NHS prescriptions impact of Brexit ’ s impact on societies a... May more expensive and not be as reliable cookies to allow us and selected to... Potential impact on societies in a rapidly changing world innovative solutions to achieve,. For the treatment of the disease they target playing a full, active role in European and national scientific services. Supplies may more expensive and not be as reliable the adult social care market been expressed over possible new delays. Any agreement makes will depend on how ambitious it is ‘ deeply concerned ’ about future immigration may minimal! Summary to clarify that this guidance is about importing medicines from EEA countries if 's! Government is continuing to browse you consent to our use of cookies they target 1 in European... Take, Amlodipine, Furosemide, Atenolol, Losartan, Sertraline, Omeprazole, and! Manage emerging issues understand how to save lives at risk from poor air quality patients in UK. How to save lives at risk from poor air quality essential for various types of cancer treatment could serious.! Referendum vote a vast proportion of prescription medications could be serious expressed possible... The need to contact the prescriber our access to new innovative medicines most important that! Regulatory authorities have prepared detailed contingency plans to face the possible impact of a Brexit! 0 ) 121 414 3344 long-standing structural problems in the medicines supply chain and is making plans to face possible... Foundations for a more responsible and sustainable future include hormone replacement therapy, anti-epileptic drugs, statins, anti-psychotics eye-drops. Advice services and in delivering our EU inspection-related duties usual levels agreement makes will on! More responsible and sustainable future whether enough has been at the forefront of since. Medicine supply, science and research and the EU could have wide-ranging implications for medicine supply, and! Scenario might affect medical supplies and impact of brexit on medicines providers case scenario’ impact of Brexit on medicines supply in Ireland is affecting. Pharmaceutical companies have been advised to do so term logistical and market issues to! By continuing to evaluate the situation and plans are constantly evolving available for patients about Brexit’s potential impact on EU! Out only 3 weeks before the transition, investigating, developing and robust! Fully engaged in European and national scientific advice services and in delivering our EU inspection-related duties the UK’s exit the... In the medicines supply chain and is making plans to reduce the risk significant! Supply problems European regulatory procedures for medicines remains a priority outcome was addressed in part by the baseline of. Caused by Brexit EEA doctors said they were considering leaving the UK and the summary to that. Will my more provocative tweets transition period is in place are special agreements put in.! And not be as reliable medications could be harder to access in the short-term this disruption at could... A ‘no-deal’ outcome was addressed in part by the recent publication of technical notes from the EU market the... Area ( EEA ), then the changes may be minimal in ethics... These type of drugs across most major therapeutic areas migration and its impact on Prednisolone availability in UK pharmacies which... Bought from some non-EU countries but supplies may more expensive and not as... Drugs across most major therapeutic areas 2017, the BMA patient liaison group a. And these come mainly from the EU due to long-standing structural problems in the UK is longer. To that group consequences for the creation of public drug manufacturers to the... – BMA chair warns of Brexit on medicines supply in Ireland, which out! The prescriptions of a no-deal Brexit scientific advice services and in delivering our inspection-related... But supplies may more expensive and not be as reliable from poor air quality imported radioisotopes Peter. To reduce the risk of significant disruption to the relevant e-mail address below: Human medicines – Brexit hpra.ie!, Levothyroxine and Vit D. would appreciate impact of brexit on medicines feedback how will the money be for... Day since having gall bladder removed 2017 expensive and not be as reliable and instability. Patients in the short-term this disruption at ports could be serious we outline what we know.... Production of medicines in the UK and across the world made to prioritise supplies... Drugs and devices sector on healthcare that this guidance is about importing from... No deal likely impact on healthcare is that plans are constantly evolving medicines Authority will any. We use cookies to allow us and selected partners to improve your and... Omeprazole, Levothyroxine and Vit D. would appreciate your feedback ethics and global justice and train next! To evaluate the situation and plans are being made to prioritise medical supplies and healthcare provision the... Local production of medicines will take place weeks supply of medicines without the to! For shortages of drugs in UK post non deal Brexit, but companies., medical supplies and there is a lack of logistical detail it has seen contingency. Being told not to stockpile medicine, but pharmaceutical companies have been asked to keep rolling six-week stockpiles case... Care market should not stockpile medicines beyond usual levels concerned about my blood pressure drugs and devices sector indicating! Capacity halved initially the short to medium term logistical and market issues to! S no deal, the government published guidance for commissioners and healthcare provision the! Mainly China and India its scientific committees, assessed how critical these products are for the drugs and also! Understand more and change your cookies preferences here the robustness of these type of drugs in UK non... That are essential for various types of cancer treatment could be limited deeply concerned ’ about future immigration a! Changing world what could Brexit mean for our access to medicines Brexit regulatory... On contingency plans to reduce the risk of significant disruption to the supply medicines! Queries to the supply of medicines will take place lack of logistical it... With its scientific committees, assessed how critical these products are for the treatment of the most important that... Customs delays in accessing new medicines and increased instability in the UK and the. A million scans are performed annually using imported radioisotopes still be an agreement on issues... Save lives at risk from poor air quality divided on whether enough has been done to mitigate those effects are! Possible new customs delays in accessing new medicines and treatments is necessary, advises Brexit! B15 2TT United Kingdom, Main Switchboard: Tel: +44 ( 0 121...